This website is intended for healthcare professionals

Sharon Rees

Associate Professor Therapeutics and Prescribing, London South Bank University

Email Sharon

SULFASALAZINE

Day 1: Convinced that rheumatoid arthritis (RA) had a bacterial cause, Professor Nanna Svartz tested sulfapyridine on her patients. After minimal success, a drug company helped her to combine this...

INCLISIRAN

Day 1: Approved in Europe in 2020, the novel lipid lowering drug #inclisiran acts on PCSK9, a known lipid pathway target; this gene therapy ‘switches off’ the enzyme (mimicking the natural mechanism...

LEVODOPA

Day 1: Still the mainstay of Parkinson's disease (PD) treatment, #levodopa was extracted from faba bean seedlings in the early 20C. It was deployed in the 1960s with dramatic ‘wakening’ effects on...

Metronidazole

Day 1: Known as an antibiotic with anti-parasitic properties, #metronidazole was discovered in the 1960s for efficacy against amoebic dysentery. This led to the accidental discovery of activity...

TIRZEPATIDE

Day 1: Following the diabetes & weight loss successes of GLP-1 agonists such as semaglutide, #tirzepatide is the 1st ‘dual’ incretin drug. Peptide engineering has been used to bring GLP-1 activity...

Drug Breakdown: Colchicine

With the help of Prescribing and Therapeutics Training Ltd and the Journal of Prescribing Practice, you can earn your 1-hour CPD certificate.

Domperidone

Day 1: After recognition that early antipsychotic drugs acting on dopamine pathways had an impact on vomiting, the search was on for an anti-emetic without extra pyramidal side-effects (EPS)....

Drug Breakdown: Fentanyl

Day 1: A synthetic opioid discovered circa 1960 (from phenylpiperidine) #fentanyl is x 50-100 more potent compared to morphine. Originally for anaesthetic i.v use; also now used for moderate-severe...

Drug breakdown: Bempedoic Acid

With the help of Prescribing and Therapeutics Training Ltd and the Journal of Prescribing Practice, you can earn your 1-hour CPD certificate.

Drug Breakdown: Isotretinoin

Day 1: A synthetic vitamin A derivative, #isotretinoin was discovered in the 1950s & originally used for skin cancer. Its effect on the cell cycle led to the discovery of efficacy for severe acne...

Drug Breakdown: Methylphenidate

Day 1: The mild CNS stimulant #methylphenidate was synthesised in the1940s & marketed as Ritalin by the 1950s, after recognition it improved concentration. Trialled for many conditions e.g chronic...

Drug Breakdown: Fosfomycin

Day 1: Originally derived from streptomyces bacteria (1960s), the main use for the synthetic oral form of #fosfomycin since the 1990s is for uncomplicated UTIs. Still available i.v for osteomyelitis,...

Drug Breakdown: Minoxidil

Day 1: A vasodilator derived from diallylmelamine in 1960s was found to have a BP lowering effect & #minoxidil was licensed 1970s. Long-term use revealed side-effect of hypertrichosis & trials for...

Drug Breakdown: Infliximab

Day 1: Monoclonal Antibody Drugs (MABs) were first generated in the 1970s and were first licensed in the 1980s for transplant rejection. The advancing technology in the 1990s led to improved B cell...

Book Review

This will be a useful and highly relevant resource for independent prescribers, whether they are clinicians considering a refresher or students/newly qualified NMPs who need a reference text. The...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP